The relationship between PD-L1 and HER2 expression in tumor cells remains controversial, although some studies have reported that PD-L1 expression in GC is positively correlated with HER2 overexpression (84.6% vs. 51.6%) [21]. Here, ERBB2 is linked to neoplasm.